What's happening
Writing a plain-English summary… Track this bill to get it by email.
Why it matters
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Headline styles
Sponsors
No co-sponsors yet.
History
- Referred to health
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Adds G6PD deficiency to the list of testing for neonatal screenings
In Assembly Committee · Health · Sponsor Darryl Towns
Full text
The text isn't available here yet. Check nysenate.gov.
Sponsor's memo
Title of bill
An act to amend the public health law, in relation to neonatal testing for glucose-6-phosphate dehydrogenase (G6PD deficiency)
Purpose
To provide life saving information for parents of newborn children.
Summary of provisions
This bill would amend subdivision (a) of the Public Health Law,
§2500-a to add glucose-6-phosphate dehydrogenase (G6PD) deficiency to the list of conditions for which newborn infants must be tested by hospitals or other institutions caring for infants less than 28 days of age.
Justification
G6PD deficiency can be a life threatening condition if not carefully managed. This common human enzyme deficiency afflicts an estimated 400 million people worldwide. The lack of this enzyme can cause anemia and other adverse symptoms. The severity of the pathologies associated with this deficiency has prompted a great deal of research and new treatment techniques are being developed. Early detection of G6PD deficiency would promote early intervention to avoid potentially serious risks through educational and social programs including a regimen of special diet.
Legislative history
S.1145/A.6568 of 2007-08 (3rd Reading 2008); S.1214/A.2358 in 2005-06 (Reported to Senate Rules 2006); S.6551/A.9905 in 2004 (Reported to Senate Rules Committee).
Fiscal implications
Undetermined. However, such cost should be minimal in comparison to the costs associated with medical care necessary to treat those in whom the disease has caused pathologies because they have been unaware of this enzyme deficiency.
Effective date
180th day following enactment; provided that the promulgation of rules or regulations needed for implementation could be enacted prior to such date.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.